6141:TSEDMG MORI CO., LTD. Analysis
Data as of 2026-06-13 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Plotech Co.,Ltd is trading at TWD 32.05, just below its 20‑day SMA of 36.69 and its 50‑day SMA of 32.26, indicating short‑term weakness despite a longer‑term bullish trend (price above the 200‑day SMA of 17.82). The MACD histogram is negative (‑1.27) and the MACD line sits beneath the signal line, reinforcing a bearish momentum in the near term, while the RSI of 43 suggests the stock is not yet oversold. On the valuation side, the forward PE of 12.57 is well under the industry average of 36.83, hinting at potential undervaluation if the projected EPS of 2.55 materializes. However, the balance sheet is strained: a debt‑to‑equity ratio of 466.9 and total debt of TWD 2.98 B dwarf the cash cushion of TWD 136 M, and profitability metrics are negative (operating margin ‑11.1%, net margin ‑29.4%). Volatility is extreme at 105% over the past 30 days, and the beta of 0.77 points to moderate market sensitivity, while the Fear‑Greed Index sits at an “Extreme Greed” 89.86, indicating a potentially overheated market environment. The stock faces moderate sector risk in the cyclical electronic components space, elevated geographic risk given its Taiwan/China exposure, and modest liquidity concerns as recent volume has slipped below its 10‑day average.
Market Outlook
Short Term
< 1 yearKey Factors
- Price below 20‑day and 50‑day SMAs
- Bearish MACD divergence
- Decreasing trading volume
Medium Term
1–3 yearsKey Factors
- Forward PE of 12.57 versus industry 36.83
- Projected positive EPS of 2.55
- Bullish long‑term trend (price > 200‑day SMA)
Long Term
> 3 yearsKey Factors
- High debt‑to‑equity ratio limiting financial flexibility
- Potential industry growth in PCB and electronic components
- Elevated volatility and geopolitical exposure
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.